Linezolid Accord Healthcare (Linezolid)

Linezolid works by binding to the bacterial 50S ribosomal subunit, which blocks the formation of the initiation complex needed for protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect against most Gram‑positive organisms and a bactericidal effect at higher drug concentrations.

The dosage of linezolid is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Healthcare professionals set the appropriate strength, frequency, and duration of therapy; patients should follow the prescriber’s instructions precisely.

Safety data for linezolid in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any possible risk to the fetus or infant. Clinicians must evaluate each case individually and discuss potential risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral bioavailability comparable to intravenous administration, making it convenient for step‑down therapy. Unlike vancomycin, it does not require therapeutic drug monitoring and is active against many vancomycin‑resistant strains. However, it may have a higher risk of hematologic toxicity and serotonin‑related reactions, so clinicians weigh these factors when selecting therapy.

Linezolid tablets should be stored at room temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Linezolid is supplied as oral tablets that are taken with or without food, as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed unless specifically advised by a healthcare professional.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome, myelosuppression, and lactic acidosis. Patients should be monitored regularly for blood‑cell abnormalities and signs of serotonin excess, especially when receiving serotonergic medications.

Linezolid is contraindicated in individuals with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in patients currently taking monoamine oxidase inhibitors (MAOIs) and used with caution in those on serotonergic agents due to the risk of serotonin syndrome.